(Q36081751)

12 August 2017

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer (English)

1 reference

12 August 2017

1 reference

1 reference

Sliutz G

1

1 reference

12 August 2017

Tempfer C

2

1 reference

12 August 2017

Winkler S

3

1 reference

12 August 2017

Kohlberger P

4

1 reference

12 August 2017

Reinthaller A

5

1 reference

12 August 2017

Kainz C

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

72

1 reference

12 August 2017

6

1 reference

12 August 2017

1494-1497

1 reference

Glycoprotein CD44 expression and its association with survival in breast cancer

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

CD44 splice variants; expression on lymphocytes and in neoplasia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

Human lymphocyte and lymphoma homing receptors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

Alternative splicing in the control of gene expression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

CD44: The hyaluronan receptor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

De-novo expression of CD44 and survival in gastric cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

Chemical composition and tissue distribution of the human CDw44 glycoprotein.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

Autolymphocyte therapy. II. Dependence of in vivo anti-tumor specificity and long-term immunity against murine melanoma and carcinoma on ex vivo activated donor memory T-cells.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

Expression and modulation of CD44 variant isoforms in humans

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034075

A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium

23 September 2018

1 reference

12 December 2020

Significance of CD44 gene products for cancer diagnosis and disease evaluation

1 reference

12 December 2020

Expression of Adhesion Molecules and c-kit on CD34+Hematopoietic Progenitor Cells: Comparison of Cytokine-Mobilized Blood Stem Cells with Normal Bone Marrow and Peripheral Blood

1 reference

12 December 2020

Peripheral Blood Stem Cell Collection after Mobilization with Intensive Chemotherapy and Growth Factors*

1 reference

12 December 2020

Serum CD44 splice variants in cervical cancer patients

1 reference

12 December 2020

Expression of CD44R1 adhesion molecule in colon carcinomas and metastases

1 reference

12 December 2020

Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa

1 reference

12 December 2020

Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression

1 reference

12 December 2020

Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.535

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8519665

1 reference